Where are you?
To give you the most accurate information about our products and what we can do for you, we need to direct you to the right site.
Media & Investors
Transparency is important to us. Find important information about Kuros Biosciences here – from our corporate documents to our current share price.
Press releases
Click each card below for our latest press releases.
For archived news items, please go to our Resources center. To subscribe to receive our press releases, please click here.
08 Jun 2022
Adhoc Press Release
Annual General Meeting of Kuros Biosciences approves all resolutions
02 Jun 2022
Adhoc Press Release
Kuros Biosciences: Completion of the acquisition of Checkmate Pharmaceuticals by Regeneron Pharmaceuticals triggers a $5 million milestone payment
Reports, Corporate Governance & Meetings
Kuros Biosciences is fully committed to good corporate governance and adherence to high ethical standards. Our principles and rules on corporate governance and ethical conduct are articulated in the Articles of Association, the Internal Regulations, the charters of the committees of our board of directors, and our code of conduct.
Analysts
Laura Pfeifer-Rossi
Octavian AG
Please use the button below to view and download Analyst reports
Calendar
| Date | Event |
|---|---|
| Mar 16, 2022 | Kuros will publish its Annual Report for 2021 |
| Jun 08, 2022 | Kuros will organize its Annual General Meeting 2022 |
| Aug 10, 2022 | Kuros will publish its Half Year Report for H1 2022 |
If you have any questions, please let us know.